- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Case for Virtual Healthcare: Dr Patricia Salber Interviews Sean Duffy of Omada Health
In healthcare, digital care and telemedicine efforts are mostly viewed as an add-on to US healthcare, but that mindset should be flipped, argued Sean Duffy, CEO of Omada Health, in a piece written for The New England Journal of Medicine, titled “In-Person Healthcare as Option B.”
In healthcare, digital care and telemedicine efforts are mostly viewed as an add-on to US healthcare, but that mindset should be flipped, argued Sean Duffy, CEO of Omada Health, in a piece written for The New England Journal of Medicine, titled “In-Person Healthcare as Option B.”
Duffy and Patricia Salber, MD, MBA, discuss the future of virtual visits, making decisions about when virtual visits are more appropriate than in-person visits, payment for virtual care, and more.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Optune Lua Device in NSCLC
October 16th 2024Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer (NSCLC) that has not responded to platinum-based treatment.
Read More
